In This Issue...
Clinical Connection: Comments, Consultation, Collaboration
Attentive audience reflects interest in laboratorians' consultative role
In this era of close scrutiny on costs, evidence-based practice, and precision medicine to provide the right treatment at the right time—the role of laboratorians in consulting with physicians to better order and interpret tests has never been more crucial. Several Annual Meeting & Clinical Lab Expo sessions will address ways that labs can collaborate more effectively with doctors in the interest of improved patient care.
In a morning Symposium on July 28 from 10:30 a.m. to 12:00 p.m. (72111), two laboratorians from Australia will take a look at how better interpretive comments affect the diagnostic process. Drs. Graham Jones and Samuel Vasikaran will describe the Patient Report Comments Quality Assurance Program, which is part of the Royal College of Pathologists of Australasia's (RCPA) Quality Assurance Program (QAP). Drs. Jones and Vasikaran will explain how the Patient Report Comments Quality Assurance Program has enabled quality assessment and continuous professional development for the interpretative support that Australian laboratorians provide physicians. If your lab has wanted to overall its interpretive comments but didn't have a good strategy for doing so, you won't want to miss this informative discussion.
Providing solid interpretive comments is one way laboratorians can work with clinicians to improve patient care. Another is through one-on-one interactions to solve everyday (as well as esoteric) clinical questions. In a morning Short Course on July 28 from 10:30 a.m. to 12:00 p.m. (72106) Drs. Howard Morris of the Hanson Institute in Adelaide, South Australia and Sutirtha Chakraborty of Peerless Hospital and B. K. Roy Research Centre in Kolkata, India will use eight clinical cases covering a variety of issues to illustrate effective laboratorian-clinician exchanges. Their emphasis will be on going beyond the raw output of lab result data to achieving bi-directional knowledge exchange that leads to a positive working relationship and more effective diagnostic testing.
Case discussions also will feature prominently in an afternoon Short Course on July 27 from 1:30 p.m. to 4:00 p.m. (192006). Drs. Udayan Ray, Joseph McConnell, and Damodara Rao Mendu will use a series of case studies to show how to communicate and collaborate with clinicians in developing the best plan for accurate and timely testing for optimal treatment. They plan to focus particularly on complex clinical pictures that clinicians often see in patients with tumors, cardiometabolic diseases, endocrine disease, and disorders of bone mineral metabolism.
Inside Track on IVD Activities
IVD industry firms showcase innovation, creativity
One of the best things about AACC's Annual Meeting & Clinical Lab Expo is that it brings together the entire in vitro diagnostics industry, from scientists performing basic research to analysts tracking the macroeconomics of the entire IVD industry or the microeconomics of individual product lines. An important element of this smorgasbord of activity is opportunities for assay, reagent, and hardware manufacturers to interface with other manufacturers and interested laboratorians.
The Expo's Original Equipment Manufacturer lecture series reflects the wealth of diversity and ingenuity in the IVD industry. These workshops, held on the exhibit floor and open to anyone in the Exhibit Hall, give products and ideas great exposure to appreciative audiences.
Arguably the session with the widest appeal is taking place July 29 from 3:00 p.m. to 4:00 p.m. In Distributor Executive Perspectives—New Realities in the Laboratory & Diagnostics Market, a panel of speakers will address issues such as how distribution is adapting to changing lab provider needs, how consolidation is affecting the industry, and how distributors expect testing locations and volume to change because of healthcare reform. The session sponsor, the Health Industry Distributors Association, has lined up a panel of healthcare distributor executives who have boots-on-the-ground perspectives on these topics.
In another broad level session, Sean Macleod, president of Stratos Product Development in Seattle will look at the contest between medical device and consumer electronics manufacturers in developing ever smaller and more capable mobile devices, apps, and connectivity platforms. As both sectors vie to produce the most relevant, user-friendly, and price-competitive products, Macleod will look at emerging trends for future success.
Representatives from at least eight other organizations will present their own innovations. From Arlington Scientific: novel in vitro multiplex enzyme immunoassay for simultaneous but separate detection and quantification of allergens, and non-treponemal enzyme-linked immunosorbent assay (ELISA) to detect non-treponemal antibody in serum. From Chek Diagnostics: updates in performance-based testing for lipids and HbA1c. From Coyote Bioscience Company, a lab-in-a-box instrumentation system based on polymerase chain reaction technology, and a novel method of one-step genetic testing without nucleic acid extraction. InDevR will be presenting its adaptable multiplexed microarray platform, while EXBIO Praha will be discussing its custom solutions for clinical immunochemical analysis. MedMira will discuss its rapid vertical flow technology, while Corning will provide guidance on optimizing ELISA-based applications using the company's Stripwell microplate. Finally, Gems Sensors & Controls will take a look at the different types of level sensing technology, how they work and when each should be used.
These dynamic sessions showcase the breadth and creativity of the IVD industry, so stop by and prepare to be impressed.